The global stoma care market size was valued at USD 487.7 million in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 6.6% from 2021 to 2028. Increasing cases of colorectal cancer and bladder cancer, Inflammatory Bowel Disease (IBD), adoption of advanced technologies and rising awareness regarding stoma care products are the key driving factors for the market. In addition, the increasing prevalence in the young population is expected to upsurge the demand for stoma care and accessories during the forecast period. The COVID-19 pandemic had a detrimental effect on the market.
The sudden outbreak of COVID-19 has postponed many ostomy procedures owing to which the demand for stoma care products has slightly decreased. In addition, the hospitals faced a surge of patients which overburdened emergency rooms (EDs), intermediate care units (ICUs), and intensive care units (ICUs) due to the COVID-19 pandemic. As a result, several ostomy surgeries were delayed which negatively impacted the market care to some extent. This impact has been the highest in the European region, especially in the U.K. and Italy. However, the stoma care products required for homecare have considerably increased due to COVID-19 as most of the patients opted for home treatments. Therefore, this factor is expected to maintain the steady growth of the market.
Several initiatives are being undertaken by various nonprofit organizations and private players to raise awareness regarding stoma care, globally. For instance, European Ostomy Association organizes World Ostomy Day (WOD) each year. It aims at improving the rehabilitation of ostomates worldwide by bringing them together. Many associations organize activities to raise awareness, such as educational programs, support meetings, and electronic information networks.
Coloplast is a leading market player that has undertaken several projects globally for creating awareness about ostomy and developing and promoting ostomy care guidelines. The company has recently published Ostomy Life Study Review to raise awareness and improve the standard of ostomy care. The review presents some of the guidelines that help in efficient patient care, such as minimizing the risk of leakage. Coloplast also supports WOD by awarding the members of the International Ostomy Association (IOA) that share their experience stories regarding stoma patients, which inspires them to live a quality life. These initiatives are expected to streamline the management of ostomy care. An increase in awareness, development of suitable reimbursement policies, and favorable policy frameworks are expected to boost investments in R&D to manufacture technologically advanced stoma care products. This in turn is expected to drive the market.
Furthermore, one of the major reasons likely to boost the market for stoma care products throughout the forecast period is the growing geriatric population. According to the World Health Organization in 2019, the global population aged 65 and up is predicted to grow from 7.00% in 2000 to 16.00% in 2050. The majority of people who have an ostomy are over the age of 50. According to the National Centre for Biotechnology Information, patients aged 70 and above have more permanent ostomy procedures than younger people, with longer hospital stays and a higher mortality rate, which is expected to raise the sale of the products.
The prevalence of colorectal cancer in North America is the highest. The increasing risk of colorectal and urinary bladder cancer has increased the demand for ostomy care products. In addition, the American Cancer Society (ACS) reported that in 2019, the number of colorectal cases in the U.S. has increased to 101,420. Thus, the growing geriatric population and increasing prevalence of colorectal cancer are expected to drive the demand for stoma care products.
In 2020, the others segment dominated the market and held the largest revenue share of 34.7%. The segment is expected to witness considerable growth rate over the forecast period. The others segment includes stoma shields, stoma caps/plugs, convex wafers/bags, barrier rings, and paste. They are required for stoma care and prevent leakage, odor, and rashes on the skin. An increase in the number of stoma operations and the number of ostomies are the major factors driving the segment.
The open/drainable bags segment is anticipated to witness the fastest growth rate over the forecast period. These bags serve as a means for the collection of waste from the body. More accessibility and low cost are the two main drivers of this segment. In addition, the increase in the prevalence of bladder cancer, urine incontinence, and spinal cord injuries has resulted in increased use of open bags.
The colostomy segment dominated the market and held the largest revenue share of 45.9% in 2020. The elderly population and the high frequency of colon cancer are the major factors driving the segment. According to the report published by the American Cancer Society, 101,420 cases of new colon cancer and 44,180 cases of new rectal cancer were reported in the U.S. in 2019. As a result, demand for colostomy bags is predicted to rise over the forecast period.
The ileostomy segment is anticipated to witness the fastest growth rate of 7.2% over the forecast period due to the rising prevalence of Inflammatory Bowel Diseases (IBDs) such as Crohn's disease and ulcerative colitis. According to the Crohn's Colitis Foundation's 2019 report, roughly 1.6 million Americans suffer from IBD and 70,000 new cases are identified each year. Furthermore, the global prevalence of colostomies, ileostomies, and urostomies was 43.0%, 41.0%, and 18.0%, respectively, according to the WHO report of 2016. During the projected period, this is expected to contribute to the growth of the segment.
In 2020, the home care settings category dominated the market and accounted for the largest revenue share of 45.4%. The rise in demand for home healthcare is expected to drive this segment over the forecast period. Homecare settings ensure ongoing stoma care by trained nurses. It provides proper care to a patient, which significantly reduces the risk of ostomy-related complications, thereby reducing emergency visits to hospitals. Moreover, patient-centric care offered by home healthcare is also expected to drive the market over the forecast period. Common home healthcare services for stoma care include maintaining healthy stoma and changing and emptying stoma bags.
The home care settings segment is predicted to grow at the fastest rate over the forecast period. The declining rate of stoma care treatment owing to the COVID-19 pandemic has made hospitals less desirable for stoma care treatment. Hospital admissions are also less desirable due to long wait times and hefty costs. Colostomy surgery for those without health insurance can cost anywhere from USD 20,000 to USD 60,000, depending on the hospital, location, and case. Over the forecast period, such high admission fees are expected to reduce the demand for hospital care.
Europe dominated the stoma care market and accounted for the largest revenue share of 47.2% in 2020. The region is expected to witness considerable growth over the forecast period. Factors such as an increase in the number of stoma patients due to Crohn’s disease and ulcerative colitis or IBD are expected to drive the growth of the market in Europe during the forecast period. In Europe, about 731,000 people live with an ostomy. According to NCBI, IBD comprises Crohn’s disease or ulcerative colitis, and its occurrence in European countries is steadily rising. According to the Journal of Crohn’s and Colitis, the incidence of ulcerative colitis and Crohn’s disease in Europe is increasing every year. It has been estimated that 0.3% of the total population in Europe suffers from IBD. The highest incidence was witnessed in the U.K., while the lowest was seen in eastern and southern Europe. Thus, the increasing incidence of IBD is primarily driving market growth in Europe.
In Asia Pacific, the market is anticipated to exhibit lucrative growth during the forecast period. Several nursing centers in this region arrange a range of programs, including motivational programs and educational seminars, to increase awareness among ostomy patients. According to Asia and South Pacific Ostomy Association (ASPOA), world ostomy day is organized every year to improve the rehabilitation of ostomates by bringing their aspirations and needs to the attention of the general public and the global community. Activities to promote awareness worldwide include seminars, educational programs, support meetings and demonstrations, electronic information networks, magazine announcements, articles and advertisements, and video and audio announcements. Thus, increasing awareness among consumers is boosting the market growth in this region.
Key players are involved in adopting strategies such as mergers and acquisitions, partnerships, and launching new products to strengthen their foothold in the market. In April 2018, Coloplast Corp. announced the addition of SenSura Mio Concave to its SenSura Mio product category. This has helped the company expand its customer base. In April 2016, Hollister Incorporated received Novation's NOVAKIDSTM Novation's Pediatric Supply Chain Program‘s Signature Supplier contract to provide hospitalized pediatric patients in the U.S. with ostomy products, support services, and educational materials. This has helped the company expand its customer base. Some of the prominent players in the stoma care market include:
B. Braun Melsungen AG
Welland Medical Limited
Market size value in 2021
USD 502.8 million
Revenue forecast in 2028
USD 785.6 million
CAGR of 6.6% from 2021 to 2028
Base year for estimation
2016 - 2019
2021 - 2028
Revenue in USD million and CAGR from 2021 to 2028
Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Product, application, end-use, region
North America; Europe; Asia Pacific; Latin America; Middle East & Africa (MEA)
U.S.; Canada; U.K.; Germany; Japan; China; Brazil; Mexico; Saudi Arabia; South Africa
Key companies profiled
Coloplast; B. Braun Melsungen AG; Hollister Incorporated; ConvaTec Inc.; Salts Healthcare; Welland Medical Limited.
Free report customization (equivalent up to 8 analyst’s working days) with purchase. Addition or alteration to country, regional, and segment scope.
Pricing and purchase options
Avail customized purchase options to meet your exact research needs. Explore purchase options
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2016 to 2028. For the purpose of this study, Grand View Research has segmented the global stoma care market report on the basis of product, application, end-use, and region:
Product Outlook (Revenue, USD Million, 2016 - 2028)
Open/ drainable Bags
Application Outlook (Revenue, USD Million, 2016 - 2028)
End-use Outlook (Revenue, USD Million, 2016 - 2028)
Regional Outlook (Revenue, USD Million, 2016 - 2028)
Middle East & Africa
b. The global stoma care market size was estimated at USD 487.7 million in 2020 and is expected to reach USD 502.8 million in 2021.
b. The stoma care market is expected to grow at a compound annual growth rate of 6.6% from 2021 to 2028 to reach USD 785.6 million by 2028.
b. North America dominated the stoma care market with a share of 19.22% in 2020. This is attributable to advanced technologies required for stoma care and raising awareness about ostomy care.
b. Some of the key players operating in the stoma care market include Coloplast, ConvaTec Inc., Hollister Incorporated, B. Braun Melsungen AG, and Salts Healthcare.
b. Key factors that are driving the stoma care market growth include the increasing prevalence of cancer, rise in the geriatric population, growing demand for non-invasive procedures, technological innovations, a rising number of government initiatives, and the impact of COVID-19.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities. Contact us now
"The quality of research they have done for us has been excellent."